News

April 8, 2019April 8, 2019

Immunosuppressant Combo Safe, Effective for Some Older Crohn’s Patients, Trial Suggests

News

Early treatment with a combination of immunosuppressant medications may be effective and safe for older patients with Crohn’s disease, as much as it is for younger patients, data from ... Read more

April 5, 2019April 5, 2019

EMA Advances Under-the-skin Injection of Entyvio for Crohn’s and Ulcerative Colitis

News

The European Medicines Agency (EMA) has accepted a Marketing Authorization Line Extension Application for a new subcutaneous (under-the-skin) form of Entyvio (vedolizumab). Entyvio is a biologic agent developed by ... Read more

April 3, 2019April 3, 2019

UK’s NICE Publishes Briefing Supporting PredictImmune Tool for Estimating IBD Flare-up Likelihood

News

The National Institute for Health and Care Excellence (NICE) supports the use of PredictImmune‘s newly launched prognostic tool, PredictSURE IBD, for estimating the likelihoood of disease flare-ups in patients ... Read more

March 29, 2019March 29, 2019

Young UMass Amherst Scientist Honored for Contributions to IBD, Colon Cancer Research

News

Food scientist Guodong Zhang, PhD, at the University of Massachusetts Amherst, has been granted the 2019 AOCS Young Scientist Research Award for his research on risk factors that contribute ... Read more

March 27, 2019March 27, 2019

Underweight IBD Patients are More Susceptible to Fatty Liver Disease, Study Suggests

News

Underweight patients with inflammatory bowel disease may be more susceptible to developing non-alcoholic fatty liver disease than those with normal weight, according to a study. The study, “Non-alcoholic fatty ... Read more

March 25, 2019March 25, 2019

NIH Grant Awarded to Advance Research on Vitamin D Treatment for IBD

News

Researchers at Loma Linda University Health have been awarded a grant to investigate if vitamin D could be used to help repair the intestine of patients with inflammatory bowel ... Read more

March 22, 2019March 26, 2019

Ozanimod Lessens Inflammation in Crohn’s, Early Phase 2 Trial Data Show

News

Daily treatment with 1 mg of ozanimod reduced gut inflammation in patients with moderately to severely active Crohn’s disease, early data from the phase 2 STEPSTONE study show. B.G. ... Read more

March 20, 2019March 20, 2019

Newly Funded Projects Aim to Improve Vaccine Use, Preventive Care in IBD

News

Some $1 million in funding will go to three projects aimed at addressing gaps in vaccine use and communication among healthcare providers and patients with inflammatory bowel disease (IBD). ... Read more

March 18, 2019March 18, 2019

Program to Examine Gut Microbiota’s Role in Predicting Response to Therapies

News

uBiome launched a research collaboration program with clinicians from the University of Louisville in Kentucky to investigate the usefulness of the gut microbiome to predict the clinical response of ... Read more

March 13, 2019March 13, 2019

First Patient Dosed in Phase 2b/3 Study of TD-1473 for Ulcerative Colitis

News

Theravance Biopharma announced that the first patient has been dosed in a Phase 2b/3 study to test the efficacy and safety of its candidate oral drug TD-1473 for the ... Read more